Alastair Hay
Vice President Peptides Almac
Seminars
Thursday 3rd December 2026
Modernizing Peptide Manufacturing Capabilities for Individualized Cancer Vaccines
9:30 am
- Promising clinical results has opened the door to exploiting the benefits of individualized cancer vaccines
- Peptides as a vaccine modality brings many benefits as described by real examples
- Standardized manufacturing brings benefits in reduced manufacturing time and costs
